A patient with pulmonary lymphangitic carcinomatosis successfully treated with TS-1 and cisplatin

被引：13

作者：

Kikuchi, Norihiro ^{[1
]}

Shiozawa, Toshihiro ^{[1
]}

Ishii, Yukio ^{[1
]}

Satoh, Hiroaki ^{[1
]}

Noguchi, Masayuki ^{[2
]}

Ohtsuka, Morio ^{[1
]}

机构：

[1] Univ Tsukuba, Inst Clin Med, Div Resp Med, Tsukuba, Ibaraki 305, Japan

[2] Univ Tsukuba, Inst Basic Med Sci, Dept Pathol, Tsukuba, Ibaraki 305, Japan

来源：

INTERNAL MEDICINE | 2007年 / 46卷 / 08期

关键词：

TS-1; cancer of unknown primary; chemotherapy; pulmonary lymphangitic carcinomatosis;

D O I：

10.2169/internalmedicine.46.6363

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 37-year-old man was referred to our hospital with complaints of dyspnea and general fatigue. Chest radiograph and CT scan revealed thickness of bronchovascular bundles in both lungs. In spite of various examinations, the primary lesion was not identified. He received chemotherapy containing TS-1 and cisplatin. Pulmonary lymphangitic carcinomatosis disappeared and the patient achieved a good partial response. He survived for 14 months after the chemotherapy. We believe the combination of TS-1 and cisplatin is one of the attractive options for patients with cancer of unknown primary site.

引用

页码：491 / 494

页数：4

共 17 条

[1] ANALYSIS OF A DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED TUMORS OF UNKNOWN ORIGIN [J].

ABBRUZZESE, JL ;

ABBRUZZESE, MC ;

LENZI, R ;

HESS, KR ;

RABER, MN .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2094-2103

[2] Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer [J].

Hideo Baba ;

Manabu Yamamoto ;

Kazuya Endo ;

Yasuharu Ikeda ;

Yasushi Toh ;

Shunji Kohnoe ;

Takeshi Okamura .

Gastric Cancer, 2003, 6 (Suppl 1) :45-49

[3] Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study [J].

Briasoulis, E ;

Kalofonos, H ;

Bafaloukos, D ;

Samantas, E ;

Fountzilas, G ;

Xiros, N ;

Skarlos, D ;

Christodoulou, C ;

Kosmidis, F ;

Pavlidis, N .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3101-3107

[4]

Greco FA, 2000, CANCER, V89, P2655, DOI 10.1002/1097-0142(20001215)89:12<2655::AID-CNCR19>3.0.CO

[5]

2-9

[6] TUMORS OF UNKNOWN ORIGIN [J].

GRECO, FA ;

HAINSWORTH, JD .

CA-A CANCER JOURNAL FOR CLINICIANS, 1992, 42 (02) :96-115

[7]

HEINZMAN ER, 1984, NEOPLASMS LUNG AIRWA, P413

[8] S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: A multi-institutional phase II trial [J].

Ichinose, Y ;

Yoshimori, K ;

Sakai, H ;

Nakai, Y ;

Sugiura, T ;

Kawahara, M ;

Niitani, H .

CLINICAL CANCER RESEARCH, 2004, 10 (23) :7860-7864

[9] Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer [J].

Kawahara, M ;

Furuse, K ;

Segawa, Y ;

Yoshimori, K ;

Matsui, K ;

Kudoh, S ;

Hasegawa, K ;

Niitani, H .

BRITISH JOURNAL OF CANCER, 2001, 85 (07) :939-943

[10] Epidemiology of unknown primary tumours [J].

Levi, F ;

Te, VC ;

Erler, G ;

Randimbison, L ;

La Vecchia, C .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) :1810-1812

← 1 2 →